Leukemia starts in cells that would normally develop into different types of blood cells. About 61,000 people in the U.S. are diagnosed each year, and depending on the type of leukemia and the age of the patient, five-year ...
Jun 8, 2022
0
27
A new research paper has been published in Aging (Aging-US), titled "Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)."
May 31, 2022
0
3
Dr. Mikhail Blagosklonny has published his new review paper titled "Hallmarks of cancer and hallmarks of aging" in Aging Volume 14, Issue 9.
May 18, 2022
0
2
In studies using mice grafted with human Ewing sarcoma tissue, researchers from Georgetown University Medical Center and colleagues have identified a biological pathway that is activated when tissue is starved of oxygen due ...
Apr 28, 2022
0
168
Casey D. Morrow, Ph.D., and colleagues at the University of Alabama at Birmingham previously developed a microbiome "fingerprint" method called WSS that identifies single strains of particular gut bacteria, through analysis ...
Apr 27, 2022
0
29
When the bacterium Helicobacter pylori infects the stomach, it causes gastric inflammation and increases the risk of stomach cancer. A team of researchers from Charité—Universitätsmedizin Berlin and the Max Delbrück ...
Apr 20, 2022
0
131
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a way to reverse resistance to a group of cancer drugs, known as kinase inhibitors, in leukemia cells. By rewiring the inner workings ...
Apr 19, 2022
0
74
While cancer therapies targeting specific genes or disease pathways can extend lives, they can also lead to highly resistant tumors when small reservoirs of cancer cells survive treatment, grow, and spread.
Mar 30, 2022
0
66
In a new article from Acta Pharmaceutica Sinica B, authors Beifen Zhong, Jun Wan and colleagues from the Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, discuss biosynthesis of rumbrins ...
Mar 8, 2022
0
2
In laboratory experiments involving a class of mutations in people with a rare collection of immune system disorders, Johns Hopkins Medicine researchers say they have uncovered new details about how immune system cells respond ...
Mar 8, 2022
0
10
